AWG Board Members

Executive Committee

Ted Schroeder

AWG Chairman of the Board
Chief Executive Officer
Nabriva Therapeutics

 

Manos Perros, Ph.D

AWG Vice Chair
Chief Executive Officer, co-Founder and Director
Entasis Therapeutics

Evan Loh, M.D.

Chair, AWG Chemistry, Manufacturing
and Controls(CMC) Subcommittee
Chief Executive Officer
Paratek Pharmaceuticals, Inc

Jeffrey Stein, Ph.D.

President and Chief Executive Officer
Cidara Therapeutics

 

Christine Ann Miller

President & CEO
Melinta Therapeutics

Christopher J. Burns, Ph.D.

Founder, President and Chief Executive Officer
Venatorx Pharmaceuticals, Inc.

Board of Directors

Robert J. DeLuccia

Co-Founder and Executive Chairman
Acurx Pharmaceuticals, Inc.

Erin Mistry

Senior Vice President of Market Access
Government affairs and Trade
CorMedix, inc.

Urs Ochsner, Ph.D.

Founder & CEO
Crestone, Inc.

Corey Fishman

Chief Executive Officer
Iterum Therapeutics

Michael N. Dudley, Pharm.D.

President and Chief Executive Officer
Qpex Biopharma, Inc.

Marco Taglietti, M.D.

Chair, AWG Antifungal Subcommittee
President and Chief Executive Officer
SCYNEXIS, Inc.

David Roblin

Chief Operating Officer, Chief Medical Officer & President of R&D
Summit Therapeutics plc

Tom Hadley

President & Chief Commercial Officer
UTILITY Therapeutics Ltd.

Stephen Conafay

AWG Washington Counsel